StockWatch: PacBio Faces Uphill Climb as Q1 Revenue Falls Short
PacBio president and CEO Christian Henry Pacific Biosciences of California (PacBio; PACB) shares plummeted 51% from $2.84 to $1.40 on Tuesday, after the long-read sequencing giant reversed its earlier “guidance” forecast to investors for 5% operating …